Dr. Andrew Frank is a cognitive and behavioural neurologist focused on early diagnosis and treatment of Alzheimer’s disease and other forms of dementia. He’s the Medical Director of the Bruyère Memory Program in Ottawa. After obtaining his MD at the University of British Columbia, he completed further training at the Ottawa Hospital and Mayo Clinic in Rochester, Minnesota.
What’s your role with ONDRI?
I’m the recruiting clinician for Alzheimer’s disease/mild cognitive impairment (MCI) and frontotemporal lobar dementia at Bruyère Continuing Care in Ottawa.
What is you hope for ONDRI?
I look forward to the results of ONDRI and other research, so that we’ll be able to diagnose neurodegeneration early and accurately, with a collection of reliable biomarkers. Then, we’ll target effective therapies to those who will benefit the most. One day, I hope the scourge/suffering of Alzheimer’s disease will be lifted.
What’s your focus?
My primary clinical interest lies in the early detection of cognitive disorders, such as MCI. My research interest centres on investigating new pharmacologic treatments for Alzheimer’s disease.
Where did you grow up?
In beautiful Calgary, Alberta.
What do you do when you’re not at work?
I spend most of my time with my wife and two young children, Emelia (age 6) and Joshua (age 3). I also enjoy writing, especially for the screen. I’m obsessed with golf, except when I’m on the ice as a hockey goalie.